age of patients receiving conventional medical care now also use complementary and alternative care, and this clearly affects how care is delivered and organized (Druss, Marcus, Olfson, Tanielian, & Pincus, 2003; Eisenberg et al., 2001) . For conventional health care providers and organized medicine, this finding also raised two immediate questions: How safe are these therapies? And what risks are involved when patients combine the use conventional and complementary therapies? This article reviews safety issues related to the use of complementary and alternative therapies, in particular as their use converges with elements of the conventional health care system.
The safety of complementary and alternative therapies must be examined within the context of a larger, complex system of health care, which includes the safety of all health care services and products. A widespread perception is that nonmainstream therapies pose a higher risk than conventional treatments, but there is no evidence to support this assumption. In fact, overall, adverse effects of complementary and alternative therapies may be relatively infrequent, compared to those of conventional medicine. Although in health care, zero treatment risk is the ideal, it is rarely achieved. The concept of relative risk is well accepted and applied in clinical practice and is particularly relevant to a discussion of complementary and alternative medicine (CAM) safety concerns.
The public's assumption that the safety of conventional medicine is guaranteed by regulations and the education and training of the health professions is also a misperception. Certainly, the incidence of deaths resulting from medical errors and adverse pharmaceutical effects should raise serious questions about the safety of conventional medical care (see the Institute of Medicine report, To Err Is Human; Kohn, Corrigan, & Donaldson, 1999) . In addition, new research continually uncovers dangers of accepted treatments that were once thought to be highly safe and beneficial. A case in point is the widely publicized study of more than 16,000 postmenopausal women concluding that hormone replacement therapy (Prempro) significantly increases the risks of coronary artery disease, stroke, and pulmonary embolism after 5 years of treatment (Writing Group for the Women's Health Initiative Investigators, 2002) . These findings contrast dramatically with the guidelines and clinical practice in treating menopause over the past 15 to 20 years: that this therapy protected women from these same health risks. A more recent incident is the withdrawal of the antirheumatic drug Vioxx because of adverse cardiac effects, after years of marketing to physicians and patients (http://www.fda.gov/cder/drug/infopage/vioxx/PHA_vioxx.htm). Thus, to fully appreciate the safety issues related to CAM, it is important to take a balanced view of the risks and safety of all forms of medical treatment.
Equally important is the understanding of the safety implications of a health care system in which complementary and conventional practices intertwine. Not only are many people using complementary and alternative therapies, but most do so in combination with conventional care (Eisenberg et al., 2001) . Different systems of health care do not simply coexist but interact, usually without guidance from the patient's respective health care providers. This complexity is compounded by widespread product marketing on the part of both pharmaceutical and complementary and alternative companies directly to the public through television and the Internet.
Risk and safety issues in health care may thus be examined from three perspectives. First, there are the issues of safety particularly relevant to conventional medicine; second, there are safety issues particularly relevant to complementary and alternative therapies; and third, there are the issues shared by both CAM and conventional care and that may be exacerbated when patients are using both types of care. This review, although focusing on safety in CAM, takes into account all three perspectives.
DEFINING SAFETY, ASSESSING RISK
Day-to-day clinical practice would benefit if it were possible to define a standard level of acceptable risk or safety threshold for all medications, herbal and nutritional products, and procedures, including surgery. Such a goal is unrealizable because an assessment of risk and safety depends on multiple, interacting factors. Patient-related factors that affect outcomes include the patient's age, gender, and race; the disease's severity, course, and progression; the patient's response to the intervention; and the patient's ability to pay for care. These combine with a variety of clinical factors, including known adverse effects of the intervention, the delivery system of treatment, the relative effectiveness of the treatment, and the clinician's expertise.
For example, the Physician's Desk Reference contains a vast array of pharmaceuticalsboth single agents and combination products-that are associated with a wide range of side effects occurring in less than 1% to 15% of patients. Therefore, advising the patient is necessarily a highly individualized and complex exercise for the health professional. In conventional medicine, effectiveness and safety of treatment are closely linked as part of the formation of standards of care over time . Although these standards are continually evolving, when counseling the patient or family, the clinician must always consider whether the test or treatment is • effective and relatively safe (e.g., a conventional hypotensive medication, acupuncture for pain or nausea, massage for low back pain, saw palmetto for benign prostatic hypertrophy),
• effective but with some potential or recognized adverse outcome (e.g., antibiotics causing allergy, ginkgo biloba causing increased bleeding tendency, St. John's wort or kava kava affecting liver function; Ernst, 2002), • unclear as to effectiveness (due to insufficient evidence) but relatively safe (e.g., short course of steroids for acute low back pain, echinacea for viral influenza, mind-body techniques for anxiety),
• unclear or questionable as to both effectiveness and safety (e.g., hormone replacement therapy for menopause (Writing Group for the Women's Health Initiative Investigators, 2002), surgery for chronic low back pain, Panax ginseng for multiple sclerosis), or • ineffective with potential or established harmful effects (e.g., chaparral).
Good clinical judgment requires knowing the toxicity, quality, and cost of the procedure or product; carefully monitoring the diagnostic test or treatment; and assessing the benefits versus the risks. The clinician's responsibilities also include communicating openly about management options, demonstrating professional competence, and ensuring ethical behavior.
Potential harm to patients comes not only from direct risks but also from financial loss due to payment for ineffective treatments, indirect damage due to delay in diagnosis or treatment, or misunderstandings due to biased or incomplete information. All can lead to undesired outcomes. A well-informed clinician with good listening and communication skills can help patients avoid adverse effects.
THE CONTEXT: SAFETY OFCONVENTIONAL HEALTH CARE
In conventional medicine, safety is generally ensured by societal agreements: that the federal government is responsible for monitoring the development and safety of pharmaceuticals and new technical procedures and that professional organizations and government agencies will oversee medical training and safe and ethical medical practice. The main agency in the government responsible for safety is the Food and Drug Administration (FDA). Health professional societies and training organizations are responsible for the ethics and competence of practitioners, and hospitals are responsible for the safety of patients and professionals working within their confines. Certifying boards operate in all states to regulate various health practices while protecting the welfare of the public. State medical boards, for example, have been required to license and monitor the quality of conventional medical practitioners since 1912. Nurses have been licensed under state nursing boards since 1903.
Although widespread, these monitoring systems are not always effective or adequate, and failure of practitioners to comply with standards and regulations often goes unreported. Recent studies have shown that health maintenance organizations and hospitals rarely report incompetent physicians as required by law and that the quality of conventional health care needs substantial improvement (Chassin & Galvin, 1998; McCormick, Himmelstein, Woolhandler, Wolfe, & Bor, 2002) .
There have been recent improvements. As of January 2001, federal law requires that Medicare patients be allowed access to their medical records if there are complaints about their care. In addition, information on disciplinary action against physicians can now be requested through the Federation of State Medical Boards Web site (www.docinfo.org). Information on incompetent physicians is also maintained in the National Practitioner Databank. Still, despite the many mechanisms developed to protect the public and ensure quality of care, problems remain. In fact, there is evidence that some patients have turned to complementary and alternative therapies because they fear the toxicity or side effects of modern drugs and treatments and because they mistrust medical providers and their institutions or means of providing care (Astin, 1998) .
The Iceberg of Safety Problems
The structure of the health care system itself leads to safety problems. Research shows, for example, that improved health outcomes correlate with well-organized primary care; however, the United States has a poorly developed primary care system (Starfield, 2000) . The reliance on health insurance as the principal way of regulating access and the constant changes in those delivery systems create numerous safety and quality assurance problems. Social and income inequality result in delayed, inadequate, and discriminatory patient care. In addition, the structure of the delivery system results in discontinuous and often poorly coordinated care by generalists as well as by specialists; poor communication among practitioners is widespread. The particularly high reliance on technology, tests, and procedures often leads to indiscriminate and costly treatment-with the accompanying potential harms such as unjustified procedures and treatment arising from false-positive results (Fisher & Welch, 1999; Starfield, 2000) .
Perhaps most significant is the power and influence of what might be called the medicalindustrial complex. This term describes the pervasive and dominating relationships among the pharmaceutical industry, health care practitioners and hospitals, medical schools, and governing agencies, including the National Institutes of Health and the FDA. Because of these entangled relationships, health care providers are enmeshed in the pharmaceutical industry's efforts to research and promote its established and emerging products. For example, there is good evidence that systematic reviews and meta-analyses of therapeutic interventions (often funded by pharmaceutical companies) focus mainly on reporting effectiveness data and give little information on safety (Ernst & Pittler, 2001) . This practice tends to downplay safety issues in favor of boosting the marketing of the drug (Angell, 2000a (Angell, , 2000b (Angell, , 2004 .
Analyses of the types of adverse effects in conventional medical care occurring in Western countries reveal significant problems in many areas, including operative errors, medication errors, and adverse pharmaceutical effects (Alberti, 2001) . Indeed, medical errors are the third leading cause of death after heart disease and cancer (Kohn et al., 1999) . Recent examples of the dangers include the following:
• Wolfe and colleagues estimated there were 103,000 serious gastrointestinal complications and 16,500 deaths related to nonsteroidal anti-inflammatory drugs (NSAIDs) in patients with arthritis, costing more than $2 billion annually (Wolfe, Lichtenstein, & Singh, 1999 • A recent meta-analysis of 39 prospective studies reported adverse drug reactions (ADRs) occurring in 6.7% of hospitalized patients. The authors estimated that in 1994, 10,600 fatal ADRs occurred (Lazarou, Pomeranz, & Corey, 1998 ).
• A 1999 Institute of Medicine study estimated that 225,000 iatrogenic deaths occur each year in the United States. Of these, 12,000 deaths are associated with unnecessary surgery. The study also reported that of 106,000 adverse effects of correctly prescribed drugs, 50% were preventable (Kohn et al., 1999 ). This problem is not confined to the United States. Worldwide, there is increasing awareness of the dangers of conventional medical practice occurring in hospitals, pharmacies, physicians' offices, nursing homes, and home care programs. The Australian government reports, for example, that preventable medical errors in hospitals are responsible for 11% of all deaths in Australia. In the United Kingdom, medical errors are the third most frequent cause of death, with 1 in 14 patients suffering adverse events such as drug reactions and diagnostic or surgical errors.
Pharmaceutical Safety
Although there has been important progress in recent decades in developing reliable, effective medications, the emphasis on and enthusiasm for effectiveness has often overshadowed issues of safety. Thus, despite federal drug regulations, use of clinical trials, and the application of chemotherapeutic principles, there remain serious safety issues related to pharmaceutical products and their applications.
In clinical settings, safety concerns include prescription and dosage errors, patient compliance, side effects, polypharmacy, and drug interactions. For example, 69% of medical injuries were judged to be due to errors in management, whereas 19.4% were due to dosage errors in writing or preparing prescriptions (Bates et al., 1995) .
A number of factors contribute to these problems. It appears, for example, that clinicians often are not sufficiently aware of the potential side effects of the vast array of available drugs. In their busy practices, they neither have nor take the time to read about them in detail. Furthermore, a practitioner cannot always rely on the medical literature to clarify the risks. A few examples illustrate the magnitude and complexity of the problem.
• In a study of outpatient prescriptions, involving 11 ambulatory clinics in Boston, patients reported an 18% complication rate (although this was recorded in only 3% of clinic charts). Significant correlates of these complications were failure to explain side effects and situations in which patients had multiple medical problems (Gandhi et al., 2000) .
• In 2000, the FDA used a fast-track process to get alosetron (Lotronex)-used to treat irritable bowel syndrome in women-approved and into pharmacies quickly. Clinical trials had shown that ischemic colitis occurred in 1 of 970 patients. After the drug entered the market, a number of patients taking this drug were hospitalized for severe constipation, bleeding, and ischemic colitis, some requiring surgery. Overall, the drug produced a therapeutic gain of only 10% to 15% over controls. It is of note that the drug was pulled from the market and is now being rereleased (http://www.pulitzer.org/year/2001/investigative-reporting/works/ willman9.html).
• Seventy-five percent of American patients receive a prescription for a pharmaceutical product from a doctor, nurse practitioner, or physician's assistant. One in five patients experience side effects, mainly from antibiotics, antidepressants, and anti-inflammatory drugs. And, in 20% of cases, the adverse effects last more than 3 months (Gandhi et al., 2000) .
• Three of four adverse drug reactions are dose-related. This is largely because manufacturers develop dosage levels to prove significant effects, although there are many patients who respond well to lower dosages. For example, the recommended dose of hydrochlorthiazide has dropped over the years from 100 mg per day to 6.25 mg. People who are sensitive to caffeine, alcohol, and over-the-counter antihistamines often respond well to smaller doses of medicines (Pharmacist's Letter, 2001) .
As these examples reveal, many medical safety problems relate to pharmaceuticals despite an apparently rigorous evaluation and testing process monitored and regulated by the FDA. The problem may lie partially in the sheer size of the agency's responsibility. The FDA monitors about $1 trillion worth of products annually, and in the past 10 years, more than 500 products have been approved for public use.
Currently, the stages of the FDA drug approval process are as follows:
Phase 1: Establish pharmacological actions and safe dosage range. Phase 2: Conduct controlled studies in animals and volunteers to assess effectiveness and safety. Phase 3: Conduct clinical trials testing larger numbers of patients in clinical settings who have the condition the drug is intended to treat. Phase 4: Conduct postmarketing surveillance studies after FDA approval and marketing of the drug. This important stage may reveal adverse effects not shown in Phase 3. Thousands of people are monitored while taking the drug, both actively (using survey and clinical evaluations) and passively (by voluntary reporting of adverse effects). Fast-track drugs: This is an accelerated approval process for drugs for patients with serious diseases who are not able to receive effective therapy.
In the past, bringing a drug to market involved four stages of clinical evaluation required by the FDA. In 1997, the Food and Drug Modernization Act streamlined the drug approval process to facilitate getting new drugs to market. Thus, only one clinical trial and surrogate end points were required to move a new drug through the approval process. This change has been severely criticized for lowering standards of drug safety. Of the products approved this way in 1998, several were eventually removed from the market because of adverse effects, including mibefradil for hypertension, dexflenfuramine for obesity, and terfenadine for allergies (Lipsky & Sharp, 2001) .
RISKS AND SAFETY OF CAM
Issues related specifically to the safety of complementary and alternative therapies can be grouped into four areas of concern. The first relates to the unique regulatory status of CAM products and practitioners. For example, because herbs and supplements are regulated as food rather than medicine, they lack the mandated efficacy and safety assurance mechanisms that are required of pharmaceuticals. A second area of concern relates to the many different approaches to testing and diagnosing illness taken by complementary and alternative practitioners. The variety in the underlying theories of illness makes standardization of clinical practices much more difficult. Third, issues of clinical competence are raised by the substantial variability in the training and standards of practice of alternative-care practitioners. A fourth area of concern involves risks and safety in the application or representation of specific products and techniques.
Safety Issues Related to Regulatory Status
In the early 1900s, state licensing laws came into effect to regulate the training and practice of conventional care providers and to protect the public from fraud and abuse. These regulations, in conjunction with the rise of biomedicine and the pharmaceutical industry, essentially marginalized other healing systems, often making them illegal.
Legislation also played an important role, setting the stage for the environment in which complementary and alternative therapies are practiced today. In 1906, the Pure Food and Drugs Act was introduced because of widespread food production scandals and deaths from bacterial contamination (Nadakavukaren, 2000) . At that time, the act required only truthful labeling of products. Subsequently, the 1938 federal Food, Drug and Cosmetic Act (FDC Act) required drugs to be tested for safety (composition, quality, labeling, and directions for use), but effectiveness of drugs was not addressed (Burdock, 2000; Lewis & Strom, 2002) .
In 1962, the Kefauver-Harris Amendments to the 1938 FDC Act required for the first time that stringent testing be used to prove that drugs were effective (Kauffman, 1995) . (Homeopathic remedies have been exempted from safety testing since 1938, perhaps because the remedies contain minimal amounts of biologically active compounds.) However, in 1994partly in response to lobbying by the dietary supplement industry and partly because of personal belief in the reported health benefits of supplements-members of Congress passed the Dietary Supplement Health and Education Act (DSHEA; Dietary Supplement Health and Education Act, 1995; Burdock, 2000; Lewis & Strom, 2002) .
Dietary supplements under the DSHEA are clearly defined and include herbs and other botanicals as well as vitamins, minerals, metabolic extracts, and amino acids (Dietary Supplement Health and Education Act, 1995). Manufacturers of dietary supplements must provide the FDA with evidence that the product is "reasonably expected to be safe" (Lewis & Strom, 2002) . The requirements for determining safety are not as stringent as are those for food additives and pharmaceutical drugs. Herbal product manufacturers need not submit results of clinical trials to substantiate safety claims; in fact, herbal substances in common use prior to the enactment of the bill are "grandfathered"; that is, they are marketed lawfully without FDA approval (Burdock, 2000) . Thus, under current law, it is the government's responsibility to show that an herb or supplement is unsafe (Burdock, 2000) . Only then are vendors forced to stop selling their product. Manufacturers now strive to follow the FDA's Good Manufacturing Practices and report this on their labels. In contrast, the German government regulates herbal products and pharmaceuticals in a similar manner in terms of safety and efficacy. The standards for approval of herbal "drugs" are more lenient than those for pharmaceuticals, however (Blumenthal, 1998) .
The United States' limited regulation of complementary and alternative products and treatments and the increasing number of patients who use CAM and conventional medicine concurrently have led to a number of broad safety-related concerns, particularly among the conventional health care community, including issues of labeling and mislabeling, misrepresentation, misapplication, misdiagnosis, substitution of appropriate therapies, interactions, double dosing, and adverse effect reporting. These concerns are addressed below as well as in the section on shared safety concerns.
Labeling and Mislabeling
Since 1999, federal regulations require that food and dietary labels be more comprehensive, showing all ingredients and the daily reference value in the label box. Minerals must be uniformly listed, and herbs and herbal extracts must be listed with their common name and Latin name.
Labeling problems often have to do with the "other ingredients" noted on the label. These usually consist of additives that help construct the product delivery vehicle: fillers (to add bulk), binders (for tablets), lubricants (to help manufacturing), coatings (to aid swallowing), and colorings. Some of these products can cause allergies, biological effects, or reduce absorption and are often given disguised names. For example, "glaze" (natural, confectioners', pharmaceutical) is a euphemism for shellac. As in conventional medicine, potential reactions may occur with food colorings, various gums, preservatives such as benzoates and propionates, and lubricants (stearates, vegetable and castor oil). The supplier may have added other ingredients without informing the purchaser.
Mislabeling occurs when the product does not contain the items listed on the label or contains ingredients with incorrect quantities or concentrations. For example, studies have shown that the amount of ginseng in most commercial ginseng products is highly variable and is generally less than indicated on the label (Cui, Garle, Eneroth, & Bjorkhem, 1994; Feifer, Fleshner, & Klotz, 2002) . Labeling also often fails to identify pharmaceuticals and toxic agents (heavy metals and pesticides) contained in herbal products (Straus, 2002) .
In response to labeling concerns, since March 2003, the FDA has drafted current Good Manufacturing Practices to "ensure that the identity, purity, quality, strength, and composition of dietary supplements are accurately reflected on the product label" (FDA, 2003a) . These new guidelines should significantly improve the quality of dietary supplements, although they will not address underlying issues of the safety of the botanical ingredient (Kroll, 2003) .
Misrepresentation or Misapplication of CAM Products or Services
Agencies (whether writers, advertisers, or health professionals) promoting therapies or products have been known to claim safety or effectiveness for treatments and diagnostic procedures that are unproven, disproven, or whose appropriate use has yet to be conclusively demonstrated. Such misrepresentation may not cause harm, and the products or treatments may be quite safe. However, the use of these treatments may be unnecessary and costly while delaying access to existing effective care. An example of such an unproven treatment would be the use of acupuncture to treat diabetes, possibly distracting the patient from seeking conventional care. Another form of misrepresentation, discussed above, is the deliberate false labeling of ingredients on a product, which can cause both harm and confusion to consumers as well as providers. For example, magnets may not deliver the magnetic field strength (Gauss) claimed by the manufacturer.
There are reports of consumers' inappropriate self-administration or self-referral of CAM therapies that have led to problems of toxicity, adverse effects, or adverse interactions with other therapies, although this issue has not been studied systematically. Such misapplication may be due to either the misrepresentation of products or services (as described above) or lack of understanding by the consumer. Other misapplications may occur because of inadequate training or experience on the part of a practitioner who recommends or administers a particular therapy. It is not uncommon for practitioners who employ CAM therapies (whether conventionally trained or otherwise) to expand the scope of their practice to include other healing modalities or products, perhaps without adequate training or experience. Variability in training and credentialing among some CAM practitioners, to be discussed later, may contribute to the potential for misapplication. For example, the education of chiropractors varies according to the training school, either including or excluding study in the use of nutritional supplements and acupuncture. Naturopathic practitioners may be trained by a 6week correspondence course or attend a 4-year postbaccalaureate degree program. The possibility of misapplication is clearly much greater for those with less training.
Adverse Effect Reporting
To understand the risks of diagnosis or treatment and to convey this information to patients, there needs to be some evidence of the frequency and severity with which adverse events occur. With many complementary therapies, adverse events may be difficult to identify. First, one often does not have adequate information about the potential for a specific adverse event. Second, patients who are using complementary therapies and their providers often fail to report abnormal events or symptoms as an adverse event (Blendon, DesRoches, Benson, Brodie, & Altman, 2001) . Third, many experts disagree on whether an adverse event has actually occurred. Fourth, aside from the surveillance system put into place at the FDA's Center for Food Safety and Applied Nutrition (CFSAN) in July 2003, called the CFSAN Adverse Event Reporting System (CAERS), there is currently no organized state or national system for reporting adverse effects of complementary and alternative therapies (FDA, 2003b) . CAERS has its limitations. Although both health professionals and the general public can report serious adverse events to herbal products as well as to foods, cosmetics, and vitamins, the FDA does not have anyone on staff with the necessary expertise to evaluate a reaction to an herbal substance (personal communication, Dr. Ken Falci, July 2003) .
In any event, a fairly large number of patients or incidents are needed to establish whether an adverse effect is linked to a particular therapy. Ideally, this information would be gathered through large clinical trials. However, thus far, these have not been undertaken in research on complementary and alternative therapies, and practical constraints make it more likely that surveillance-type epidemiological data will be used to indicate effects (Ernst & Pittler, 2001) .
International reporting systems do exist, although the classification of adverse effects is in its infancy (Farah, Edwards, Lindquist, Leon, & Shaw, 2000) . A study in the United Kingdom showed that about 26% of consumers of herbal products do not report minor or serious adverse effects to their physicians or pharmacists, although they would do so for a problem with conventional medication. This suggests that there may be future problems in identifying the adverse effects of complementary and alternative therapies (Barnes, Mills, Abbott, Willougby, & Ernst, 1998) . Many CAM therapies are considered "natural" and assumed to be without harm (Matthews, Lucier, & Fisher, 1999) . This assumption is valid for a number of practices, such as meditation, spiritual healing, and homeopathy. However, some therapies have potential dangers and should be used with caution. Adverse events have even been documented with psychic practices such as voodoo. Chelation therapy and some dietary supplements can be harmful in certain situations. Adverse effects from dietary supplements may be related to the botanical ingredient itself or to contaminants; examples include the introduction of steroids into "natural" imported products for body builders (Wang, Wen, & Shiao, 1997) .
SAFETY CONCERNS IN DIAGNOSTIC AND TESTING PROCEDURES
When complementary and alternative practitioners employ diagnostic procedures and testing processes that are unfamiliar and quite different from those used by conventional clinicians, there may be concern about the necessity, accuracy, and safety of these methodologies. For many of these procedures, although there is no research suggesting that they are harmful, neither is there research that establishes their efficacy. Thus, questions about their usefulness and risk remain.
Diagnostic Procedures
In CAM, certain diagnostic methods are used that are either unrecognized in conventional medicine or have not been validated. The unfamiliarity of these methods per se does not make them unsafe or invalid. Consistency, reliability, face validity, and usefulness in determining outcomes may indicate safe and valid practice. Research suggests that some CAM diagnostic techniques are valid, reliable, and useful, whereas others are not. For example,
• Traditional Chinese medicine diagnosis of specific problems is generally consistent and reliable (Zhang, Bausell, Lao, Handwerger, & Berman, 2003) .
• Chiropractic uses X rays extensively, although they have been shown to be of little value in treatment outcomes (Ernst, 2001a) .
• Manual assessment of joint dysfunction has moderate validity and interobserver reliability (French, Green, & Forbes, 2000; Najim et al., 2003) .
• Reflexology, based on the premise that stimulation of reflexes enhances autoregulation and thus healing, practices palpation of the feet, guided by charts that show representative organs and parts of the body on the foot surface. Palpation is said to reveal dysfunctional reflexes in the body, with an abnormal feel in one particular area suggesting some dysfunc-tion of the representative organ or a disease state. However, interobserver reliability studies of reflexology show poor correlations between experienced practitioners (Ernst, 2001a) .
• Iridology, based on the belief that organs and body regions are represented at a specific location on the iris of the eye, assesses the patient's condition by inspection and enlarged photographs of the eye. This system has not been shown to produce clinically useful diagnoses (Ernst, 2001a) .
Conventional practice may view variability in diagnosis as invalidating. However, from the perspective of many complementary medicine practitioners, because diagnosis is based on the assessment of multiple data sources arising from personal, contextual, and physical factors that may be interpreted differently by different clinicians, variability in diagnosis may be quite acceptable.
Although certain nonconventional diagnostic techniques may be of relatively little use, they may pose little or no risk to the patient. Even the concern that diagnosis using complementary medicine techniques may delay the implementation of conventional investigation may be unfounded. There are no data to support this fear.
Laboratory Testing: Conventional Medicine
In general, risk and safety issues are not a problem in conventional laboratory testing because of the very rigorous quality assurance programs dictated by federal authorities. There are, however, always problems of variability, accuracy, and reliability of test results that must be taken into account by the clinician, especially if the test result seems unusual or does not fit the clinical picture (Sox, 1996) .
Variability in test results in conventional laboratories can occur as a result of the following:
• Biological variability: the variability of physiology between patients or in one patient at different times, which involve such factors as gender, race, and age. This is why laboratories provide reference ranges of test results to clinicians.
• Pretesting variability: involving such factors as food intake, exercise, stress level, medications, and over-the-counter drugs taken by the patient just before the test.
• Analytic variability: the variability of laboratory measurement (materials, equipment, personnel skills, and procedures). This may be due to inaccuracy or imprecision and is minimized by rigorous analytic method monitoring and quality assurance using standards set out by national (American College of Pathologists) and federal laboratory regulations. All affiliated conventional laboratories participate in regular proficiency testing programs.
• Postanalytic variability: comes from errors in reporting (e.g., transcription, identification, which affect a test's sensitivity and specificity).
The American College of Pathologists provides regular reports of error rates and quality assurance programs for laboratories all over the country (Rock, 1994) .
Nonconventional Laboratories
With the growth in the use of complementary and alternative therapies, there has been a parallel increase in the number of laboratories that serve the particular philosophies and diagnostic strategies of their practitioners. In general, these approaches are based on the concept that human health and illness are highly susceptible to the toxic effects (metal, chemical, radiation) of the environment and to the intake of synthetic products (including foods and drugs). Theoretically, such poisoning of the body can be rectified by avoiding and removing exposures, with special biological, dietary, and herbal treatments, and by cleansing and chelation (removal from the blood) regimens. These different tests and their interpretation do not escape the quality and accuracy problems identified for conventional laboratory tests. Moreover, mainstream laboratory science remains skeptical about many of these claims of scientific usefulness, and little research has been done to evaluate their effectiveness.
Consequently, conventional clinical laboratories are concerned with four issues in relation to complementary diagnostic testing:
• Some conventional clinicians and a variety of complementary practitioners are using nontraditional laboratories for special types of testing, such as measuring antioxidant defense levels to assess the patient's susceptibility to cancer.
• Many nonconventional laboratories do tests for which there is, so far, little clear evidence that what is measured relates causally with clinical problems.
• With wider use of herbals and supplements, more incidents of interaction and toxicity may occur, expanding the need for laboratory investigation. Many conventional laboratories may not possess the technology and trained personnel to evaluate these problems.
• There is increasing realization that some of the substances used in complementary medicine, or their metabolites, interfere analytically with routine conventional laboratory tests.
Nontraditional laboratories specialize in functional assessment and the identification of a variety of environmental toxins, bacterial and fungal imbalances, and food and organism allergies (Great Smokies Diagnostic Laboratory, 2004; York Nutritional Laboratories, 2004) . These laboratories are extensively used by naturopaths and clinicians practicing holistic or ecological medicine and provide testing not offered in conventional laboratories. Conditions for which tests are ordered include acne, asthma, cystitis, dental caries, depression, autism, attention deficit disorder, seizure disorders, candidiasis, irritable bowel syndrome, fibromyalgia, chronic fatigue syndrome, and postmenopausal problems. Most of these services are not reimbursable by insurance and may cost several hundreds of dollars (Ernst & Hentschel, 1995) .
Reliability of test results performed through a nonconventional laboratory can be assessed by checking whether the laboratory is in compliance with the Clinical Laboratory Improvement Act (CLIA) of 1988 and is licensed by the state. Such laboratories must conduct regular proficiency tests against a national standard and are regularly inspected and certified. Of about 200 nontraditional laboratories studied recently, 80% were not participating in the CLIA program. (For a full report, see CLIA Regulation of Unestablished Laboratory Tests at http://oig.hhs.gov/oei/reports/oei-05-00-00250.pdf.)
The kinds of testing services performed at nonconventional laboratories are illustrated by the Great Smokies Diagnostic Laboratory (http://www.gsdl.com) in Asheville, North Carolina, which is certified by the CLIA. Its services to more than 8,000 clinicians include the following: • Immunology assessment: comprehensive antibody and allergy assessment on serum (immediate and delayed IgG) for 120 different types of food and many nonfood compounds.
• Nutritional assessment: elemental analysis of hair and blood for 20 elements (such as arsenic, cadmium, nickel, copper, tin, amino acids) and 40 essential and metabolic fatty acids, to detect causes of unexplained symptoms, blood deficiencies, or deviations from normal laboratory values.
• Endocrinology assessment: sex and regulatory (e.g., thyroid) hormones in men and women.
Identifying bone resorption (osteoporosis), usually using blood or salivary secretions.
• Metabolic assessment: body detoxification processes, oxidative stress, antioxidant defense, and cardiovascular markers.
• Toxic element exposure profile: in-depth assessment of exposures from a variety of industrial chemicals and chemical products encountered in daily life (e.g., aluminum, arsenic, barium, bismuth, cadmium, copper, lead, mercury, nickel), usually tested on hair, blood, and urine. Some clinicians and many patients believe that this type of toxicity may play a role in attention deficit disorder, Alzheimer's disease, Parkinson's disease, weakened immunity states, increased cancer risk, and gastrointestinal dysfunction.
• Hair testing: hair testing is used to assess nutritional status and toxic element exposure based on the organic substances trapped in the hair and has been internationally approved as a reliable method of monitoring biological exposures if careful collection and analytic procedures are followed.
Several factors have an important impact on test outcomes, including sample collection and results interpretation. Samples must be collected carefully. Hair specimens, for example, are often contaminated from sweat, environmental agents, and cosmetics; other samples may be affected by daily fluctuations in metabolism. Finally, as with many conventional tests, interpreting results is a complicated process: Slightly abnormal results and false positives may be unclear and difficult to interpret.
ENSURING CLINICAL COMPETENCE
State medical licensing laws were implemented in the early 1900s to protect the public from abuse, fraud, and mistreatment. These laws were linked to the process of ensuring reasonable and ethical standards of practice, necessary because the quality of medical practice was highly variable and the medical system was in disarray. For example, in those days, it was possible to obtain a mail-order medical degree after only 6 weeks of home study for a cost of $200. The licensing laws also served to ensure that only those with specific training from certain medical schools could legally practice. Others who called themselves healers could be prosecuted and jailed for practicing medicine without a license. Only religious healers were exempted. Thus, the licensing laws created a medical guild that not only purportedly protected the public but also protected its own entrenched discipline and reduced public choice in seeking other kinds of care. In fact, the American Medical Association (AMA), between 1930 and 1970, aggressively tried to suppress or prosecute alternative practitioners such as chiropractors. In 1987, the AMA was convicted by a federal court ruling of unreasonable restraint of trade and violating antitrust laws (Wilks v. AMA).
The competence of conventional physicians, nurses, and pharmacists is now generally assumed and accepted by the public and government agencies. It is based on rigorous and well-tested training, continuing education requirements, recertification examinations, the monitoring of practice by professional boards, and the control and punishment of incompe-tence by professional organizations. How well this system actually works is unclear, but evidence for problems can be found in the substantial numbers of complaints, malpractice suits, and disciplinary actions that occur annually. Safety concerns may arise when conventional health care providers, well trained in their conventional specialty, practice CAM therapies with inadequate training or experience. For example, physicians in some states may practice a CAM therapy such as homeopathy or acupuncture with no additional certification.
Recent changes in the delivery of health care have resulted in proposals for regulatory reform for all health professionals to provide a more flexible scope of practice (Pew Foundation, 1995) . Although regulation of health professionals was designed to protect the public, it can create barriers to access for patients and cause professional turf conflicts (Reinhardt, 1996) .
Credentialing Practitioners of CAM
In the United States, formal recognition of clinical competence may be a challenge for some practitioners of CAM who have not been through approved training programs and national board examinations in their discipline or those who live in states where there is no state licensure. The expected standards of competence and responsibility also relate to the degree of autonomy or supervision under which these clinicians practice. For example, an autonomous CAM practitioner may be expected to have a sufficient amount of medical knowledge to recognize medical conditions or early warning symptoms Ernst, 1995) .
Today, most professional organizations for complementary and alternative modalities have requirements for membership that include training, defined supervision, and testing. Licensing of complementary and alternative practitioners, through multidisciplinary or singlediscipline state boards, has evolved slowly over the past few years and is in a constant state of flux. In states where licensing boards exist to monitor adequacy of training and quality of practice (e.g., chiropractic, acupuncture, homeopathy, and naturopathy), the practitioners can practice legally, therefore offering the public some assurance of their competence.
In those states without licensing, the ability to monitor training, competence, and fraud is limited. In some states, unlicensed practitioners may be subject to criminal prosecution, whereas in other states, health freedom laws provide a measure of protection. Referrals to effective and safe complementary and alternative clinicians may therefore depend more on local reputation and personal knowledge than on ascertaining licensing status. To find out whether a certain discipline is licensed in the state, it is necessary to call the state medical board or health department or study the Web site appropriate to the discipline. Most complementary disciplines have national organizations of practitioners, and many have referral services.
This variability in the legal standing of complementary practitioners creates uncertainty for all concerned and prevents a more integrative approach to health care. Referrals between conventional and complementary care providers may have malpractice implications in the event of a lawsuit (Cohen, 2000) . Ethics regarding the interaction between conventional medicine and CAM are unclear (Ernst, 2001b) . To what degree should conventional practitioners be bound to offer or recommend nonconventional treatment options to patients? If conventional practitioners offer complementary therapies or refer to a CAM practitioner, what ethical responsibilities do they have to understand the therapy's benefits and risks? What knowledge should they have regarding the competence of the practitioner? Safety con-siderations would suggest that conventional providers have sufficient understanding of the risks and benefits of therapies and the competence of providers to which they refer. This understanding should be reflected in their documentation of rationale and intended benefits.
The establishment of legal and regulatory standards for CAM is still in its early stages. Conventional clinicians who practice nonconventional, complementary therapies may be at some risk related to the scope of their practice and also may be subjected to disciplinary action by state medical boards based on prevailing norms and state laws. Malpractice rates are substantially lower for licensed practitioners of CAM compared to conventional generalist clinicians (Studdert et al., 1998) .
SAFETY ISSUES OF BOTANICALS AND NUTRITIONAL SUPPLEMENTS
The majority of safety issues in complementary and alternative care arise from the inappropriate or indiscriminate use of botanicals (including herbals) and nutritional supplements (also called nutraceuticals or dietary supplements). Patients often believe that organic or natural products are inherently safe, and safety is therefore not a concern (Matthews et al., 1999) . Another belief that may pose risks for those who self-treat is that more is better and can produce a speedier beneficial effect.
Safety of botanicals and nutritional supplements thus relates to three issues: first, the potential for interactions between botanicals and conventional medications; second, the possibility of toxicity from supplements or contaminants (which may be difficult to detect); and third, the potential, theoretically, for nonconventional laboratories to cause harm through high cost to the client, while using unreliable methods for testing that have not been proven to affect health outcomes.
Botanicals and nutritional supplements, like other biological agents, act at multiple sites in the body and produce many effects, some of which may not be detectable on routine clinical or toxicology testing. Few conventional laboratories can successfully identify the active agents of these botanicals because of ignorance of their metabolism and where to look for the evidence (urine, liver, blood, etc.) . The one exception is that toxicity screening can usually reveal contamination of herbal products by heavy metals. It may be useful to monitor certain laboratory values while patients are taking a botanical remedy or nutritional supplement because of potential adverse effects.
Health Risks Associated With Botanical Products
Botanicals, including herbal products, although derived from natural substances, are the forerunners of synthetic pharmaceuticals. Like medications, they have biological actions, which is why many herbal products are regulated as drugs in Europe (Mills & Bone, 2000) .
Many herbal therapies are quite safe and fall into the realm of foods. Examples include Western tonic herbs traditionally consumed as teas, such as chamomile, nettle, and red clover. Other herbs, termed heroics, have a history of adverse effects well known to traditional herbalists and have been employed specifically because of their toxic properties (Mills & Bone, 2000) . An example may be the use of bloodroot as an escharotic for treating skin cancers, as popularized by Frederick Mohs, M.D. (Alleger, 1999) .
A number of problems can occur when taking botanical products. Reactions to therapy can be immediate or delayed, often as a result of a main pharmacological action. Between 1997 and 1998, for example, 140 adverse events (hypertension, arrhythmias, stroke, seizures, and death) were reportedly caused by dietary supplements containing ephedra (Ma Huang), usually in combination with caffeine. These products are widely used for weight reduction and enhancement of physical activity (Haller & Benowitz, 2000) . Three billion doses of ephedra were sold in 1999, giving an adverse reporting rate of 10 per 1 billion. More recently, it was reported that there were 12,000 complaints to the company making Metabolife 365 (containing ephedra), with the result that the FDA stopped the public sale of ephedra (Fontanarosa, Rennie, & DeAngelis, 2003; Marcus & Grollman, 2002) .
Unpredictable reactions can also be associated with short-or long-term therapy. Some adverse events have been recognized only recently, perhaps in part due to differences in traditional versus modern usage of botanicals. In addition, lack of knowledge about proper dosing may result in inappropriate use by consumers. For example, liver damage has been documented to be associated with the extended use of chaparral or kava kava, herbs traditionally taken short term. Other unpredictable toxicities occur from accidental or purposeful substitution of one substance with another, such as digitalis toxicity from the contamination of plantain with digitalis glycosides (Escher, Desmeules, Glostra, & Mentha, 2001) .
In general, however, the epidemiology of adverse events from herbs is not well known. The FDA's CAERS system for reporting adverse events to food, dietary supplements, and cosmetics is just getting off the ground (FDA, 2003b) . In Sweden, a European adverse event system collects data from 55 countries (Farah et al., 2000) . Adverse event reporting systems are limited in their ability to define the true incidence of reactions to botanical products or drugs due to their inability to define the denominator (the number of consumers using the herbal product or drug in question). The systems perform best in capturing acute, serious events (Rodriguez, Staffa, & Graham, 2001) .
Contamination
Herbal products pose a risk from contamination with pesticides, heavy metals (cadmium, mercury), pharmaceuticals, and micro-organisms (Slifman et al., 1998) . For example, a study of herbal stores in California showed that 35 of 251 products had unacceptably high levels of mercury (Talaly & Talaly, 2001) . In Canada, Hua Fo, a Chinese herbal product claimed to enhance sexual function, was recently found to contain Viagra (Health Canada Online, 2002) . In February 2002, the California State Health Department found that PC-SPES (an eight-herb traditional Chinese remedy used for prostate hypertrophy and for lowering prostate-specific antigen levels) was contaminated with diethylstilbestrol (feminizing hormone) and warfarin (anticoagulant; Straus, 2002) . Random testing of traditional Chinese medicine products in Britain showed continued evidence of banned substances (mercury, arsenic) in products (Medicines and Healthcare Products Regulatory Agency, 2004).
Potency and Bioavailability
The strength and bioavailability of herbal supplements may be different from traditional preparations as a result of manufacturers' using different extraction processes. This leads to potential alterations in potency for the active compounds or the extraction of new compounds, with their corresponding effects (DeSmet, 1999) . Also, seasonal variation in growing conditions and harvesting can affect the potency of a product (Valli & Giardina, 2002) .
Dosing
Dosing recommendations for herbs lack uniformity and vary depending on how the herb is prepared or on the manufacturer's recommendations.
Double Dosing
Patients often take many different commercial CAM products at the same time. Many botanicals and nutritional supplements sold to the public are branded for different health maintenance and prevention purposes, such as "antiaging," "menopause," or "cholesterol defense formula." Thus, it is fairly easy to take multiple sets of many of the same ingredients, particularly if labels are unclear about the ingredients. The mail-order company Bronson, for example, sells Anti-Aging, a "complete men's formula that contains 12 vitamins, 8 elemental nutrients, and 5 herbs for prostate, cardiac, and immune health." Based on this form of marketing, patients may take several doses of the same herb or vitamin and not be aware of the total dosage.
Allergies
Herbs may also produce allergic reactions. These may be from allergies to the herb itself or to excipients-the delivery vehicle in which the product is placed such as lanolin, propylene glycol, and binders and fillers in capsules or tablets.
Direct Toxicity
Also of concern is toxicity of compounds in the herb. For example, Aristolochia fangchi, a Chinese herb used in weight reduction treatments, contains nephrotoxic aristolochic acid that can provoke genitourinary cancers. The incidence of adverse effects to St. John's wort is 1% to 3%, photosensitivity being the most frequent problem (Schultz, 2000) .
Herbal Remedies and Surgery
A special risk posed by herbal products is their possible impact on surgical safety. It is particularly important to identify whether patients are taking certain herbal remedies when they are evaluated for surgery involving anesthesia, as the interaction between many herbals and anesthesia can be dangerous. Worrisome is a 1998 study of cardiothoracic surgery patients, showing that although the overall CAM use rate was 44% (excluding prayer and vitamins), only 17% had discussed this usage with their surgeons (Liu et al., 2000) .
Seven herbs-accounting for a large fraction of all preparations sold in the United States-have been identified as having potential pharmacological effects relevant to surgical procedures. These are as follows:
• ephedra, whose sympathomimetic effects may affect the hemodynamic state; • garlic, which inhibits platelet aggregation and may increase bleeding tendency;
• ginkgo, which may increase bleeding tendency; • ginseng, which lowers blood glucose and may increase bleeding;
• kava kava, which may increase the sedative effect of anesthetic and affect liver function;
• St. John's wort, which affects metabolism of steroids, warfarin, calcium channel blockers, digoxin, and many other drugs; and
• valerian, which increases the sedative effect of anesthetic and may increase anesthetic requirements.
Although there is still relatively little research proving adverse effects related to surgery and anesthesia, recommendations are to discontinue use of these supplements 5 to 7 days before surgery (Ang- Lee, Moss, & Yuan, 2001) .
Health Risks Associated With Nonherbal Nutraceuticals
Nonherbal nutraceuticals include vitamins, minerals, phytonutrients, and animal extract and tissue products. Examples include blue-green algae, bee pollen, glandular extracts, and protein powder. Product quality, including purity, is again an issue, but the main safety problems have to do with the following:
• Excessive dosage: Some consumers may believe that more is always better and may thereby ingest toxic quantities, for example, too much vitamin A or calcium.
• Allergies to fish or animal protein are not unusual and may occur from bee sting or dried (animal) cell therapy.
• Meats, liver extracts, and ghee (Indian butter) may harbor microorganisms such as salmonella or Clostridium tetani.
• Toxic metals (such as arsenic, cadmium, lead, and mercury) or other contaminants can be purposefully or accidentally added to traditional and homeopathic preparations and cosmetics. Recently, it was reported that some Ayurvedic formulations contained substantial variations of arsenic (0.0027 ppm to 1,675 ppm; Itankar, Sakharkar, & Chandewar, 2001 ).
• Diets and vitamins: Overzealous use of unbalanced diets can lead to nutritional deficiencies, changes in physiological function, and changes in responses to conventional medications. Excessive beta-carotene causes yellow skin, too much vitamin D leads to hypercalcemia and gastrointestinal problems, and substantial vitamin E doses cause a coagulopathy.
• Contamination of combination products with undeclared substances: A study by Consumer Lab (2002) found that up to 10% of some mineral supplements in the United States were contaminated with lead, calcium was contaminated with an antibiotic, Chinese diet pills contained fenfluramine, there were excessive amounts of vitamin A in Metabolife bars, and nettle products were contaminated with lead.
Interference With Analysis of Laboratory Tests
Botanicals and nutraceutical products can interfere with the analysis of laboratory tests, posing a potential safety threat when undetected. For example,
• Digoxin measurement is affected by Siberian ginseng, Chan Su, milkweed, uzara root, and lily of the valley. Chan Su (from secretions of toads) is a major component of the traditional Chinese remedies Liu Shen Wan and Kyushin.
• Ephedra (Ma Huang) may affect workplace and athletic urine testing for performance enhancers (cross-reacts with amphetamine antibodies).
• Creatine supplements affect creatine testing.
• Herbal weight loss products interfere with catecholamine testing.
SAFETY OF THREE COMMONLY USED COMPLEMENTARY THERAPIES
In addition to an understanding of safety issues related to CAM botanical and dietary products, conventional practitioners should be aware of the risks-if any-posed by other commonly used complementary and alternative therapies. Three are highlighted here because of their widespread use. Chiropractic and osteopathy are among the manual therapies widely and regularly used by Americans. For example, 11% to 16% of the population visits a chiropractor, whereas 25% of patients with low-back pain do so . About 30% of all visits to CAM practitioners are to chiropractors; in one study, 65% of physicians reported that they had referred one or more patients to a chiropractor (Meeker & Haldeman, 2002) . Acupuncture and homeopathy are also commonly used alternative therapies. In 1998, for example, Americans made more than 5 million visits for acupuncture treatment, and approximately 2 million visits were made to homeopaths . Although there may be some risks associated with these therapies, they appear, overall, to be relatively safe.
Manual Therapy
Manual therapies involving manipulation of joints and the spine have been practiced for centuries and have evolved into the disciplines of chiropractic and osteopathy. There are now many educational programs with osteopathic training requiring 4 years of medical school with additional postdoctoral training in manipulation. Osteopathic physicians are now part of mainstream medicine. In addition, a number of short courses in manual therapy-ranging from a half-day to 2 weeks-are offered to conventional primary care physicians by the American Academy of Physicians and schools of osteopathy. Limited manual therapy is also part of the training of physical therapists.
Adverse events from manipulation may occur, but most are mild, usually causing localized discomfort, headache, or fatigue (16% of visits). A recent meta-analysis of five prospective studies showed that about 50% of patients receiving manipulation experienced mild transient reactions (Ernst, 2001c) . Other adverse effects can arise out of misdiagnosis (missing cancer or metastases) or manipulating joints that are either severely inflamed or affected by other serious diseases (rheumatoid arthritis, bone infection, dislocations, myelopathy). However, no serious complications have been noted in more than 70 controlled trials (Meeker & Haldeman, 2002) .
Of the serious problems that do occur, most have involved cervical spine manipulation. Assendelft, Bouter, and Knipschild (1996) reviewed the world's literature (mostly singlecase reports) over the past 30 years and identified a total of 295 reported complications of spinal manipulation, most performed by chiropractors (61%). There were 39 fatalities over a 30-year period. In 165 of the 295 cases, vertebrobasilar strokes from cervical manipulation occurred. In 61 cases of low-back pain, there was deterioration of a herniated disk or progression to cauda equina syndrome. A more recent self-report survey of 323 British neurologists found 74% reporting complications of manual therapy within 24 hours of receiving chiropractic treatment and identified 35 cases with serious complications (Stevinson, Honan, Cooke, & Ernst, 2000) . The reported incidence of complications varies from 1 per 2,500 manipulative procedures to 1 per 1 million (Klougart, Leboeuf-Yde, & Rasmussen, 1996) . Unfortunately, few long-term prospective studies have been done to clarify this issue (Ernst, 2001c) . In addition to the direct adverse effects of manipulation, indirect effects include the excessive use of X rays in evaluating spinal problems and prolonged manipulation treatment beyond recommended national guidelines.
To put these numbers in context, one should consider the adverse effects of NSAID use for low-back pain and neck pain. Gastrointestinal symptoms occur in 3% to 20% of patients. The odds ratio for gastrointestinal perforation (often asymptomatic) is 3.7 for aspirin, 6.7 for other NSAIDs, and 1.0 for placebo (Aronson, 1996) .
Acupuncture
Most adverse effects from acupuncture are mild and transient. Aggravation of symptoms occurs in about 13% of patients (Rampes & James, 1995) . Other adverse effects include fainting, increased pain, nausea, and vomiting. Infections, including hepatitis B and C and bacterial infections, have rarely been reported, and when they occur, most bacterial infections have responded to antibiotic therapy. The use of disposable needles has eliminated most of these problems. Needle punctures causing hematomas and injury to the lungs (pneumothorax) have been reported (Ernst & White, 1997) . Electromagnetic acupuncture needle stimulation should not be used if the patient has a cardiac pacemaker. A recent review of case reports of the adverse effects of acupuncture identified only 202 incidents in 35 years, from 22 countries. Adverse effects have been declining in recent years because of clean needle techniques and more rigorous training (Lao, Hamilton, Fu, & Berman, 2003; White, Hayhoe, Hart, & Ernst, 2001) .
Homeopathy
Homeopathy is based on the use of highly dilute solutions of natural substances. Clinical practice is generally safe: there are no major reports of adverse effects and little evidence of direct toxic effects of homeopathic remedies. One small survey showed that about 10% of patients taking homeopathic remedies reported some adverse effect, which was frequently an aggravation of the symptoms being treated, often perceived by the homeopath as a positive response to therapy (Ernst, 2001a) .
SAFETY OF CAM IN PEDIATRICS
Increasing numbers of children and adolescents are using complementary therapies and nutritional supplements (Gardiner, Conboy, & Kemper, 2000) . Typically, youngsters using complementary and alternative therapies suffer from chronic, usually recurrent conditions such as acne, asthma, sleep problems, attention deficit hyperactivity disorders, premenstrual syndrome, obesity, and urinary infections. In particular, chiropractic care for families has expanded, so that in 1993, children made an estimated 20 million visits to chiropractors. Nearly a third of all visits to homeopaths and naturopaths are by children and adolescents (Lee & Kemper, 2000) .
Other than the safety issues already discussed, two main issues cause concern to conventional pediatricians. First, a number of homeopathic, naturopathic, and chiropractic practitioners (probably about 10%-15%) believe the risks of immunization outweigh the benefits and will advise families against the practice (Ernst & White, 1995) . Second, it is theoretically possible (though not substantiated) that children with acute illnesses might receive delayed appropriate treatment if the complementary and alternative practitioners persist too long with their approach.
SHARED SAFETY ISSUES OF CONVENTIONAL AND COMPLEMENTARY MEDICINE
Several safety concerns occurring at the interface of complementary and conventional treatments are shared almost equally by both types of practitioners, from their varying perspectives.
Substitution for or Delay of Appropriate Therapy
Indirect safety risks may result from the substitution of a more invasive or ineffective therapy for the "appropriate" therapy. (Of course, in medicine, there is always uncertainty about what is actually appropriate for an individual patient in a given situation.) This problem is often seen within conventional medicine, as in a surgeon's being too quick in recommending back surgery before the patient has explored less invasive therapeutic options. CAM practitioners share this concern-that patients may be denied safer, less invasive treatments due to either their practitioners' lack of knowledge about these therapies or lack of access (financial or otherwise) to these treatments. Conventional practitioners often have a similar concern with respect to CAM therapies: The fear is that a patient might delay or substitute use of a safe, effective conventional therapy so as to use a riskier, unproven alternative or that the patient who is receiving appropriate conventional therapy may stop it despite health risks on the recommendation of a CAM practitioner. An example is the case of a middle-aged woman with diabetes whose CAM provider recommends that she stop oral hypoglycemic drugs before starting to use a traditional Chinese remedy and whose diabetes consequently goes out of control.
It is important to note that substitution for or delay of "appropriate" therapy may not necessarily pose a safety risk. There are many paths to healing, and patient choice plays an important role in the healing process. Harm may result from conventional providers who summarily dismiss the use of any complementary or alternative therapy for "lack of evidence of efficacy," thus dissuading patients from using potentially helpful therapies. It may well be that the evidence for effectiveness exists but that the clinician is unaware of it. The real issue is one of information transfer and communication. In all fields of medicine, it is essential that there be communication between clinicians about their respective treatment strategies for an individual patient. Serious risks may arise when one practitioner's treatment supersedes another and when the respective clinicians are not in communication.
Negative Interactions Between CAM and Conventional Medicine
Of particular concern are problematic interactions between conventional medications and dietary supplements. After all, 1 in 6 adults taking prescription drugs also takes at least one herbal product (Kaufman, Kelly, Rosenberg, Anderson, & Mitchell, 2002) . Although some interactions are life threatening, other, subtler problems may also result. A complementary product or treatment might counteract a medication, dilute its effects, or enhance its properties, creating an inadvertent "overdose." And often the effect is not obvious and may thus compound over time. One example occurs in organ transplant therapy when blood levels of cyclosporin and indinavir are significantly decreased on ingestion of St. John's wort, resulting in rejection of the transplanted organ ("Drug Interactions," 2000) . St. John's wort taken for longer than 14 days also alters the metabolism of other conventional medications by affecting liver enzyme function (Wang et al., 2001) . On the other hand, homeopathic practitioners are often concerned about the effects of drug regimes on their ability to make an accurate case because symptoms of the patient's illness may be confused with medications' side effects.
Misdiagnosis by the Clinician
Risks are incurred when the clinician fails to detect the actual medical problem or assigns the wrong diagnosis to the patient. This is particularly likely when the diagnosis is governed by a very narrow diagnostic paradigm. For example, iridology uses patterns in the iris of the eye, reflexology uses patterns on the soles of the feet, and electrodiagnostic instruments (the neurocalometer developed by chiropractic in the 1930s) are used by chiropractors to recognize diseased organs.
Of course, diagnostic problems also commonly occur in conventional medicine, either by missing the diagnosis, making the incorrect diagnosis, or "overdiagnosing" the problem (Chassin & Galvin, 1998) . Missing the diagnosis, which results from errors of omission, such as not doing an adequate physical examination, failing to do an appropriate test, or misinterpretation of test results, most often occurs in primary care. Overdiagnosing, which results from errors of commission, such as identifying a prolapsed lumbar disk that "requires" surgery or getting a false-positive test for benign prostatic hypertrophy, tends to occur most often in specialist care. Also in conventional medicine, laboratory errors that may lead to invasive testing and treatment by the clinician are quite frequent (Sox, 1996) .
LACK OF COMMUNICATION, EDUCATION, AND TRAINING ABOUT CAM
The recent final report of the White House Commission on Complementary and Alternative Medicine (2002) advises clinicians and patients to "become more knowledgeable about the potential benefits and harms of CAM approaches" and urges "physicians and other health professionals [to] make significant efforts to open lines of communication with their patients about their use of CAM." The reason for this recommendation is simple. Although not integrated with conventional care, complementary and alternative therapies form a major component of the contemporary health care system, and the uncoordinated, ill-informed blending of these systems poses safety risks.
In general, risks arise as the result of incomplete knowledge on the part of the clinician, leading to errors in decision making and therapy. Among the possible problems are the following:
• Health professionals are often unaware that the patient is being treated by other conventional or complementary and alternative care providers.
• Health professionals are not fully aware of the medications and herbal or nutritional supplements taken by the patient (e.g., Eisenberg and colleagues, 1998 , found that two thirds of patients did not discuss CAM with their conventional caregivers).
• There is a lack of communication between health professionals, possibly leading to conflicting diagnoses, advice, and therapy.
• There is a lack of respect between clinicians, based on biases, poor esteem, ignorance of training and skills, and concern about legal and financial risks.
These misunderstandings may result, at least, in reduced benefit to the patient or, at worst, in serious errors in treatment decisions. It should be noted that some of these problems are just as frequent within the conventional health care system, either between different specialties or between primary and specialist care. However, they are likely to be compounded in instances involving complementary and alternative treatment. A number of risks specific to the CAM-conventional care overlap may arise for patients, including • disagreement regarding diagnosis;
• lack of knowledge of the interactions between herbs, supplements, and conventional medications;
• potential for unnecessary health care costs due to duplication of tests and clinical management; and
• lack of laboratory and clinical methods to evaluate the effects of CAM biological products.
CONCLUSION
The convergence of conventional, complementary, and alternative health care systems raises important questions about quality, effectiveness, and safety. Not only must conventional clinicians educate themselves about unfamiliar therapies, but health care providers also generally need to understand the implications of the overlapping of multiple systems of care. The 2005 Institute of Medicine report, Complementary and Alternative Medicine in the United States, argues strongly for more regulation and quality control of herbal and dietary products, better research to demonstrate effectiveness of CAM interventions, and, most important, much more effort at educating conventional health professionals about these issues.
The best way to address these safety issues, for clinicians and patients alike, is to be informed. Health care providers need to learn about the various modalities in use, to understand how to find and evaluate information sources, and to share information effectively with patients, colleagues, and complementary practitioners. plinary UNC Integrative Medicine Clinic. She has played a leadership role in implementing the Planetree model at UNC Health Care. Her research interests include outcome studies of specific complementary therapies for various conditions, health beliefs and care pathways, geriatrics, and women's health issues.
